ClinicalTrials.gg

BiologicalDrug

Lipopolysaccharides clinical trials

studies test it
14
open now
2
in phase 3
0
first study started
2007

Keep track of what changes. Save the Lipopolysaccharides studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

14 studies that test it; most in 2017 (3)

Studies that test Lipopolysaccharides, by start year
YearStudies
20071
20091
20111
20131
20141
20173
20181
20211
20232
20242

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
8
Phase 2
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 1 · Other 13

Yale University (3) · University of California, Los Angeles (2) · Patrick Wagner, MD, FACS (1) · Laureate Institute for Brain Research, Inc. (1) · GlaxoSmithKline (1) · Karolinska Institutet (1) · University of Nottingham (1) · Radboud University Medical Center (1)

Often tested with

Tested in the same studies.

Granulocyte-Macrophage Colony-Stimulating Factor (1) · Leucine (1) · Theophylline (1)

Studies

Open first, then newest update. How each study uses Lipopolysaccharides is read from its arms, and is right about nine times in ten.

Testing it · 14

Given in every arm · 6 — Lipopolysaccharides is usual care beside what is tested

Codes

What other systems call Lipopolysaccharides · ClinicalTrials.gg INT007741

  • MeSH (NLM) D008070LipopolysaccharidesOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.